Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.14726 http://scihub22266oqcxt.onion/10.18632/oncotarget.14726 C5386777!5386777 !28103585     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28103585 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Oncotarget 2017 ; 8 (12 ): 20462-20475 Nephropedia Template TP {{tp|p=28103585 |t=2017. Long non-coding RNAs in osteosarcoma |pdf=|usr=}}{{28103585 }} gab.com Text Long non-coding RNAs in osteosarcoma JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28103585 #FOAvip Long non-coding RNAs (lncRNAs) with more than 200 nuleotides, have been explored to participate in various cancer types including osteosarcoma (OS), which is the most common kind of primary bone tumors with high morbidity in infants and adolescents. These oncogenic or tumor suppressive lncRNAs regulate OS pathogenesis, such as cell growth, proliferation, invasion, migration, metastasis and cell apoptosis, serve as independent prognostic biomarkers or play a significant role in multidrug resistance (MDR) in OS cells. In this review, we attempt to dissect the participation of lncRNAs in pathogenesis of OS and their potential clinical values, and also provide an outlook for viable biomarkers and therapeutic targets in OS. Twit Text FOAVip Long non-coding RNAs in osteosarcoma ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28103585 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28103585 #FOAvip English Wikipedia <ref>{{Cite pmid|28103585 }}</ref> Long non-coding RNAs in osteosarcoma #MMPMID28103585 Chen R ; Wang G ; Zheng Y ; Hua Y ; Cai Z Oncotarget 2017[Mar]; 8 (12 ): 20462-20475 PMID28103585 show ga Long non-coding RNAs (lncRNAs) with more than 200 nuleotides, have been explored to participate in various cancer types including osteosarcoma (OS), which is the most common kind of primary bone tumors with high morbidity in infants and adolescents. These oncogenic or tumor suppressive lncRNAs regulate OS pathogenesis, such as cell growth, proliferation, invasion, migration, metastasis and cell apoptosis, serve as independent prognostic biomarkers or play a significant role in multidrug resistance (MDR) in OS cells. In this review, we attempt to dissect the participation of lncRNAs in pathogenesis of OS and their potential clinical values, and also provide an outlook for viable biomarkers and therapeutic targets in OS. |Animals [MESH] |Bone Neoplasms/*genetics/*pathology [MESH] |Humans [MESH] |Osteosarcoma/*genetics/*pathology [MESH]Long non-coding RNAs in osteosarcoma (epmc).pdf DeepDyve Pubget Overpricing